Interpretation of the Methylation Pathways Panel (2011)

Richard A. Van Konynenburg, Ph.D. Independent Researcher (richvank@aol.com) Disclaimer: The Methylation Pathways Panel is offered by the European Laboratory of Nutrients in the Netherlands and the Health Diagnostics and Research Institute in New Jersey, USA. I am not affiliated with these laboratories, but have been a user of this panel, and have written these suggestions at the request of Tapan

Glutathione Depletion-Methylation Cycle Block: A Hypothesis For the Pathogenesis of Chronic Fatigue Syndrome by Richard A. Van Konynenburg Ph.D.

Independent Researcher and Consultant, (richvank@aol.com) INTRODUCTION AND HYPOTHESIS. At the Seventh International Conference of the AACFS in 2004, the author proposed and defended the hypothesis that glutathione depletion is an important part of the pathogenesis of CFS (1). In the conclusions of that paper it was noted that it seemed likely that there are vicious circle mechanisms involved in CFS

A Simplified Treatment Approach Based on the Glutathione Depletion-Methylation Cycle Block Pathogenesis Hypothesis for Chronic Fatigue Syndrome (CFS) by Rich Van Konynenburg, Ph.D.

(Some Headings and Formatting added by Cort Johnson) Part I: Theory and History Introduction. I first want to note that I am a researcher, not a clinician, and that what I have to say here should not be interpreted as medical advice. In January, 2007, in an effort to shed light on the validity of the Glutathione Depletion-Methylation Cycle Block

Simplified Treatment Approach Based on the Glutathione Depletion- Methylation Cycle Block Pathogenesis Hypothesis for Chronic Fatigue Syndrome (CFS) by Rich Van Konynenburg, Ph.D. II

Part II: the Treatment Plan Introduction. (Repeated From Part I) I first want to note that I am a researcher, not a clinician, and that what I have to say here should not be interpreted as medical advice. In January, 2007, in an effort to shed light on the validity of the Glutathione Depletion-Methylation Cycle Block (GD-MCB) Pathogenesis Hypothesis for

Suggestions for Treatment of Chronic Fatigue Syndrome based on the Glutathione Depletion-Methylation Cycle Block Hypothesis: The Simple Approach

Richard A. Van Konynenburg, Ph.D. I presented the Glutathione Depletion-Methylation Cycle Block Hypothesis for the pathogenesis of CFS in a poster paper at the 8th international conference of the International Association for Chronic Fatigue Syndrome in Ft. Lauderdale, Florida, on January 10-14, 2007. This poster paper is available here: Since then I have received requests from some clinicians for a

Glutathione and the Methylation Cycle by Rich Van Konynenburg Ph.D.

Rich Van Konynenburg, Ph.D., an independent researcher, believed that glutathione depletion causes many of the problems in ME/CFS. The master anti-oxidant in the body, glutathione also plays a role in amino acid transport, protein synthesis, the cell cycle and immune cell proliferation. These papers by Rich Van Konynenburg examine ways to enhance glutathione, detoxification and energy production in ME/CFS. Rich

Treatment Protocols

In a perfect world one would simply find a chronic fatigue syndrome (ME/CFS) specialist and visit him or her. In our imperfect world such specialists are rare and often charge fees that are too high for many financially challenged people with ME/CFS. This does not, of course, mean there is no hope. There are basic steps that many of us can

Clinical Study of Simplified Yasko Protocol for CFS and Fibromyalgia

Posted by Cort Johnson Clinical Study of Simplified Yasko Protocol for CFS/fibromyalgia Rich Van Konynenburg, Ph.D. Independent Researcher/Consultant richvank@aol.com Neil Nathan, M.D. Gordon Medical Associates Santa Rosa, CA Yasko Protocol Conference – Boston July 30-August 1, 2010 • Type: Open-label clinical study • Setting: A single private practice in Springfield, Missouri • Informed consent: Patients signed forms after explanation of

Continue

Application of Yasko Protocol to the Treatment of Chronic Fatigue Syndrome by …

Posted by Cort Johnson Application of the Yasko Protocol to the Treatment of Chronic Fatigue SyndromeRich Van Konynenburg, Ph.D. Independent Researcher/Consultant richvank@aol.comNeil Nathan, M.D. Gordon Medical Associates Santa Rosa, CA info@gordonmedical.com Yasko Protocol Conference – Boston July 30-August 1, 2010 ____________________________________ Disclaimers 1. People undergoing treatment for chronic fatigue syndrome as discussed in this talk must be under the care

Continue

Chronic Fatigue Syndrome Treatments

Currently there are no nationally-approved drug treatments in any country for chronic fatigue syndrome (ME/CFS), except in Argentina, where Ampligen is approved. A few specialist doctors have their own ME/CFS treatment protocols; patients who cannot find such specialists must work with their own doctors to seek treatment for their individual symptoms. Many ME/CFS patients experiment on their own. To discuss